US Food and Drug Administration (USFDA) has completed inspection of the facility of Granules India’s wholly owned foreign subsidiary -- Granules Pharmaceuticals, Inc., on January 17, 2020 with three minor observations. This is a pre-approval inspection for a product filed from this facility. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.
Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1906.30 |
| Dr. Reddys Labs. | 1365.20 |
| Cipla | 1471.15 |
| Zydus Lifesciences | 1151.50 |
| Lupin | 2502.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: